Eslicarbazepine acetate: An efficacy and safety as an antiepileptic drug in clinical trials and open studies

• Main Authors: Martyna Stefaniak (Author), Zofia Pietrzak (Author), Piotr Dzikowski (Author), Emilia Nowicka (Author), Michał Obel (Author), Halina Piecewicz-Szczęsna (Author)
• Format: Book
• Published: Kazimierz Wielki University, 2022-02-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

Eslicarbazepine acetate (Zebinix®, ESL), a voltage-gated sodium channel blocker, is a once-daily, orally administered anti-seizure medication available in the EU for use as monotherapy in adults with newly diagnosed partial-onset seizures and as adjunctive therapy in adults, adolescents, and childre...